• Air Traffic Control
  • Govt Finance Report
  • Pension Reform
  • Events
  • Reason facebook
  • Reason twitter
  • Reason youtube
Reason Foundation
  • About
    • About Us
    • Contact Us
    • Email Newsletters
    • Events
    • FAQs
    • Jobs & Internships
    • Savas Award
    • Shop
    • Staff
    • Trustees & Officers
  • Experts

      Browse Our Experts

      • Aaron Smith
        Director of Education Reform
      • Adrian Moore
        Vice President of Policy
      • Baruch Feigenbaum
        Senior Managing Director, Transportation Policy
      • Geoff Lawrence
        Research Director
      • Guy Bentley
        Director of Consumer Freedom
      • Leonard Gilroy
        Vice President of Government Reform
      • Robert Poole
        Director of Transportation Policy
      • Vittorio Nastasi
        Director of Criminal Justice Policy
      • View All Experts
  • Topics

      Browse Our Topics

      • Air Traffic Control
      • Annual Highway Report
      • Consumer Freedom
      • Criminal Justice Reform
      • Drug Policy
      • Education
      • Gov’t Financial Transparency
      • Pension Reform
      • Technology
      • Transportation
      • Urban Growth and Land Use
      • View All Topics
  • Publications
    • Latest
    • Government Financial Project
    • Annual Highway Report
    • Annual Pension Report
    • Annual Privatization Report
    • Aviation Newsletter
    • Backgrounders
    • Commentaries
    • Data Visualization
    • Education Newsletter
    • Email Newsletters
    • Pension Reform Newsletter
    • Policy Studies
    • Psychedelics Newsletter
    • Public Schools Without Boundaries
    • Testimony
    • Transportation Newsletter
    • Amicus Briefs
  • Reason.com
  • Donate
    • Donate Online
    • Donate Crypto
    • Ways To Give
    • Torchbearer Society
    • Planned Giving

Psychedelics Policy Newsletters

The Psychedelics Policy Newsletter examines the latest psychedelics policy news and developments.

If you would like to receive the Psychedelics Policy Newsletter via email, please enter your email address below.

Previous issues of this newsletter are below and Reason Foundation's drug-related research is available here.

Sign up for the Psychedelics Policy Newsletter

This field is for validation purposes and should be left unchanged.

  • Psychedelics Policy Newsletter: DEA considers rescheduling psilocybin, FDA releases rejection decision, and more
    Psychedelics Policy Newsletter: DEA considers rescheduling psilocybin, FDA releases rejection decision, and more

    Plus: Reason Foundation testifies in Mississippi, author Joe Dolce talks about his new psychedelics book, and more.

    By Gregory Ferenstein
    October 6, 2025

  • Psychedelics Policy Newsletter: RFK Jr. gives hopeful approval timeline, Arizona advances ibogaine, and more
    Psychedelics Policy Newsletter: RFK Jr. gives hopeful approval timeline, Arizona advances ibogaine, and more

    Plus: Former Texas Gov. Rick Perry on his strong commitment to advancing ibogaine as a treatment.

    By Gregory Ferenstein
    August 12, 2025

  • Psychedelics Policy Newsletter: FDA prioritizes drug reform for psychedelics, Texas advances ibogaine research, and more
    Psychedelics Policy Newsletter: FDA prioritizes drug reform for psychedelics, Texas advances ibogaine research, and more

    Plus: New psychedelics-related hire at the Department of Health and Human Services, update on state progress, and more.

    By Gregory Ferenstein
    June 16, 2025

  • Psychedelics Policy Newsletter: Reforms for Congress, data for rescheduling, and more
    Psychedelics Policy Newsletter: Reforms for Congress, data for rescheduling, and more

    Plus: State regulation progress and more.

    By Gregory Ferenstein
    April 9, 2025

  • Psychedelics Policy Newsletter: States propose legalization, optimism for Trump administration nominee, and more
    Psychedelics Policy Newsletter: States propose legalization, optimism for Trump administration nominee, and more

    Plus: A policy brief on psychedelics and neurodegenerative treatments, alternatives to 'double-blind' trials, and more.

    By Gregory Ferenstein
    February 4, 2025

  • Psychedelics Policy Newsletter: Trump administration recommendations, Massachusetts loss, and more
    Psychedelics Policy Newsletter: Trump administration recommendations, Massachusetts loss, and more

    Plus: Government funding for addiction research, veteran’s administration pursues psychedelics, and more.

    By Gregory Ferenstein
    December 11, 2024

  • Psychedelics Policy Newsletter: MDMA rejection, advocating for lower state fees in Colorado, and more
    Psychedelics Policy Newsletter: MDMA rejection, advocating for lower state fees in Colorado, and more

    Plus: A profile of ibogaine advocate Bryan Hubbard, the Drug Enforcement Administration head worries about ketamine, and more.

    By Gregory Ferenstein
    September 30, 2024

  • Psychedelics Policy Newsletter: A glimpse into Colorado after psychedelics legalization, a gathering of conservative legislators, and more
    Psychedelics Policy Newsletter: A glimpse into Colorado after psychedelics legalization, a gathering of conservative legislators, and more

    Plus: Food and Drug Administration approval of MDMA is tentative, the psychedelic origins of Whole Foods, and more.

    By Gregory Ferenstein
    July 31, 2024

  • Psychedelics Policy Newsletter: Massachusetts ballot initiative would foster access, state legislature momentum stalls, and more
    Psychedelics Policy Newsletter: Massachusetts ballot initiative would foster access, state legislature momentum stalls, and more

    Plus: The National Institute of Health awards money for addiction research, a Michigan poll signals interest in psychedelics, and more.

    By Gregory Ferenstein
    May 31, 2024

  • Psychedelics Policy Newsletter: A retail system model, ibogaine research, and legalization updates
    Psychedelics Policy Newsletter: A retail system model, ibogaine research, and legalization updates

    A model that would reduce costs and increase consumer access to psychedelics by streamlining the overall regulatory burden.

    By Gregory Ferenstein
    March 28, 2024

  • Psychedelics Policy Newsletter: Impactful ibogaine study, bill introduced in New Hampshire, and more
    Psychedelics Policy Newsletter: Impactful ibogaine study, bill introduced in New Hampshire, and more

    Plus: State news roundup and the defense spending bill calls for research on using psychedelics to treat PTSD in military members, and more.

    By Gregory Ferenstein
    January 25, 2024

  • Psychedelics Policy Newsletter: California’s steps after bill vetoed, Kentucky ibogaine funds, and more
    Psychedelics Policy Newsletter: California’s steps after bill vetoed, Kentucky ibogaine funds, and more

    Plus: New Drug Policy Handbook, the latest on implementing Colorado's legalization, and more.

    By Gregory Ferenstein
    November 28, 2023

Follow

  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • RSS

Email Updates

Get weekly updates from Reason.

This field is for validation purposes and should be left unchanged.

More About Reason Foundation

  • About
  • Contact
  • Donate
  • Email Newsletters
  • Events
  • Jobs and Internships
  • Policy Research
  • Reason magazine
  • Shop

Contact

Reason Foundation
5737 Mesmer Ave.
Los Angeles, CA 90230
(310) 391-2245

1630 Connecticut Ave NW
Suite 600
Washington, DC 20009
(202) 986-0916

Privacy Policy
Accessibility

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
Copyright © 2025 Reason Foundation